Open Access

[Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells

  • Authors:
    • Yu-Hua Chen
    • Bi-Yun Zhou
    • Xian-Jing Wu
    • Jun-Fa Xu
    • Jun‑Ai Zhang
    • Yong-Hua Chen
    • Si-Si Liang
  • View Affiliations

  • Published online on: December 16, 2020     https://doi.org/10.3892/or.2020.7903
  • Pages: 786-786
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2021
Volume 45 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Zhou B, Wu X, Xu J, Zhang JA, Chen Y and Liang S: [Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells. Oncol Rep 45: 786-786, 2021
APA
Chen, Y., Zhou, B., Wu, X., Xu, J., Zhang, J., Chen, Y., & Liang, S. (2021). [Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells. Oncology Reports, 45, 786-786. https://doi.org/10.3892/or.2020.7903
MLA
Chen, Y., Zhou, B., Wu, X., Xu, J., Zhang, J., Chen, Y., Liang, S."[Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells". Oncology Reports 45.2 (2021): 786-786.
Chicago
Chen, Y., Zhou, B., Wu, X., Xu, J., Zhang, J., Chen, Y., Liang, S."[Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells". Oncology Reports 45, no. 2 (2021): 786-786. https://doi.org/10.3892/or.2020.7903